Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Global challenges in breast cancer detection and treatmentBarrios, C.H.Breast (Edinburgh), 2021-04, Vol.56, p.S3 [Periódico revisado por pares]ElsevierTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCCKnox, J.J. ; Barrios, C.H. ; Kim, T.M. ; Cosgriff, T. ; Srimuninnimit, V. ; Pittman, K. ; Sabbatini, R. ; Rha, S.Y. ; Flaig, T.W. ; Page, R.D. ; Beck, J.T. ; Cheung, F. ; Yadav, S. ; Patel, P. ; Geoffrois, L. ; Niolat, J. ; Berkowitz, N. ; Marker, M. ; Chen, D. ; Motzer, R.J.Annals of oncology, 2017-06, Vol.28 (6), p.1339-1345 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
VP6-2021: IMpassion050: A phase III study of neoadjuvant atezolizumab + pertuzumab + trastuzumab + chemotherapy (neoadj A + PH + CT) in high-risk, HER2-positive early breast cancer (EBC)Huober, J. ; Barrios, C.H. ; Niikura, N. ; Jarzab, M. ; Chang, Y-C. ; Huggins-Puhalla, S.L. ; Graupner, V. ; Eiger, D. ; Henschel, V. ; Gochitashvili, N. ; Lambertini, C. ; Restuccia, E. ; Zhang, H.Annals of oncology, 2021-08, Vol.32 (8), p.1061-1062 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
SA 1.5 - Global challenges in breast cancer detection and treatmentBarrios, C.H.Breast (Edinburgh), 2021-04, Vol.56, p.S3-S3 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1–selected NSCLCSpigel, D. ; de Marinis, F. ; Giaccone, G. ; Reinmuth, N. ; Vergnenegre, A. ; Barrios, C.H. ; Morise, M. ; Felip, E. ; Andric, Z.G. ; Geater, S. ; Özgüroğlu, M. ; Mocci, S. ; McCleland, M. ; Enquist, I. ; Komatsubara, K.M. ; Deng, Y. ; Kuriki, H. ; Wen, X. ; Jassem, J. ; Herbst, R.S.Annals of oncology, 2019-10, Vol.30, p.v915 [Periódico revisado por pares]Texto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Exploring disparities in incidence and mortality rates of breast and gynecologic cancers according to the Human Development Index in the Pan-American regionMartínez-Mesa, J ; Werutsky, G ; Michiels, S ; Pereira Filho, C.A.S ; Dueñas-González, A ; Zarba, J.J ; Mano, M ; Villarreal-Garza, C ; Gómez, H ; Barrios, C.HPublic health (London), 2017-08, Vol.149, p.81-88 [Periódico revisado por pares]Netherlands: Elsevier LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Correction to: 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)Cardoso, F. ; Costa, A. ; Senkus, E. ; Aapro, M. ; André, F. ; Barrios, C.H. ; Bergh, J. ; Bhattacharyya, G. ; Biganzoli, L. ; Cardoso, M.J. ; Carey, L. ; Corneliussen-James, D. ; Curigliano, G. ; Dieras, V. ; El Saghir, N. ; Eniu, A. ; Fallowfield, L. ; Fenech, D. ; Francis, P. ; Gelmon, K. ; Gennari, A. ; Harbeck, N. ; Hudis, C. ; Kaufman, B. ; Krop, I. ; Mayer, M. ; Meijer, H. ; Mertz, S. ; Ohno, S. ; Pagani, O. ; Papadopoulos, E. ; Peccatori, F. ; Penault-Llorca, F. ; Piccart, M.J. ; Pierga, J.Y. ; Rugo, H. ; Shockney, L. ; Sledge, G. ; Swain, S. ; Thomssen, C. ; Tutt, A. ; Vorobiof, D. ; Xu, B. ; Norton, L. ; Winer, E.Annals of oncology, 2017-12, Vol.28 (12), p.3111-3111 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trialMontemurro, F. ; Delaloge, S. ; Barrios, C.H. ; Wuerstlein, R. ; Anton, A. ; Brain, E. ; Hatschek, T. ; Kelly, C.M. ; Peña-Murillo, C. ; Yilmaz, M. ; Donica, M. ; Ellis, P.Annals of oncology, 2020-10, Vol.31 (10), p.1350-1358 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancerGennari, A. ; André, F. ; Barrios, C.H. ; Cortés, J. ; de Azambuja, E. ; DeMichele, A. ; Dent, R. ; Fenlon, D. ; Gligorov, J. ; Hurvitz, S.A. ; Im, S.-A. ; Krug, D. ; Kunz, W.G. ; Loi, S. ; Penault-Llorca, F. ; Ricke, J. ; Robson, M. ; Rugo, H.S. ; Saura, C. ; Schmid, P. ; Singer, C.F. ; Spanic, T. ; Tolaney, S.M. ; Turner, N.C. ; Curigliano, G. ; Loibl, S. ; Paluch-Shimon, S. ; Harbeck, N.Annals of oncology, 2021-12, Vol.32 (12), p.1475-1495 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysisEmens, L.A. ; Adams, S. ; Barrios, C.H. ; Diéras, V. ; Iwata, H. ; Loi, S. ; Rugo, H.S. ; Schneeweiss, A. ; Winer, E.P. ; Patel, S. ; Henschel, V. ; Swat, A. ; Kaul, M. ; Molinero, L. ; Patel, S. ; Chui, S.Y. ; Schmid, P.Annals of oncology, 2021-08, Vol.32 (8), p.983-993 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |